Spindle Biotech News Today

STONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a public

Award Seeks to Demonstrate Feasibility of Manufacturing mRNA Vaccines in Only 7 Days

Applied DNA Announces 1-For-20 Reverse Stock Split

STONY BROOK, NY / ACCESSWIRE / April 22, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be effective as of 12:01 a.m. Eastern Time on Thursday, April 25, 2024. App...

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering ...

STONY BROOK, NY / ACCESSWIRE / February 2, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that it has closed its previously announced registered direct offering of its common stock priced at-the-market under Nasdaq rules with certain existing in...

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) ...

Applied DNA Sciences, Inc. and Kudo Biotechnology announced their entry into a joint development agreement to integrate Applied DNAs Linea IVT platform into Kudo Bios commercial mRNA manufacturing...

Operator: Good Day and welcome to the Applied DNA Sciences Fiscal Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results ...